Basic Information
LncRNA/CircRNA Name | LINC00526 |
Synonyms | NA |
Region | GRCh38_18:5236724-5238598 |
Ensemble | ENSG00000264575 |
Refseq | NR_026849 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | glioma |
ICD-0-3 | NA |
Methods | qPCR, Western blot, RIP |
Sample | Human normal glia cell line NHA, and glioma cell lines LN18, U87, U251 and U138, Human glioma tissues, Normal brain tissues |
Expression Pattern | down-regulated |
Function Description | a novel lncRNA LINC00526, which is significantly low expressed in glioma. Low expression of LINC00526 is correlated with aggravation and poor survival in glioma. Functional assays revealed that ectopic expression of LINC00526 inhibits glioma cell prolifera- tion, migration, and invasion. LINC00526 silencing promotes glioma cell proliferation, migration and invasion. Mechanistically, we found that LINC00526 directly interacts with EZH2, represses the binding of EZH2 to AXL promoter, attenuates the transcrip- tional activating roles of EZH2 on AXL, and therefore represses AXL expression.Via re- pressing AXL, LINC00526 further represses PI3K/Akt/NF-?B signalling. Intriguingly, we identified that NFKB1 and NFKB2 directly binds LINC00526 promoter and re- presses LINC00526 transcription. We further found that via activating NF-?B sig- nalling, AXL represses LINC00526 transcription. |
Pubmed ID | 31240814 |
Year | 2019 |
Title | Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL |
External Links
Links for LINC00526 | GenBank HGNC NONCODE |
Links for glioma | OMIM COSMIC |